These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6357071)

  • 21. Homogeneous substrate-labeled fluorescent immunoassay for disopyramide in human serum: semi- and fully automated procedures.
    Johnson PK; Messenger LJ
    Clin Chem; 1986 Feb; 32(2):378-81. PubMed ID: 3510781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Plasma level of dibekacin in children with mucoviscidosis. Comparison with a control population].
    Loeuille GA; Cournol R; Delnatte J; Martin G
    Ann Pediatr (Paris); 1987 Nov; 34(9):713-7. PubMed ID: 3426082
    [No Abstract]   [Full Text] [Related]  

  • 23. Homogeneous substrate-labeled fluorescent immunoassay for carbamazepine.
    Li TM; Miller JE; Ward FE; Burd JF
    Epilepsia; 1982 Aug; 23(4):391-8. PubMed ID: 7047157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of dibekacin in children with cystic fibrosis.
    Courcol RJ; Loeuille GA; Delnatte J; Martin GR
    Int J Clin Pharmacol Res; 1985; 5(2):87-91. PubMed ID: 4018945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dibekacin intrarenal distribution characteristics and renal cortical elution kinetics. Comparison with gentamicin and tobramycin.
    Whelton A; Carter GG; Stout RL; Herbst DV; Bryant HH; Walker G
    J Clin Pharmacol; 1980; 20(8-9):518-25. PubMed ID: 7430416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sisomicin, netilmicin and dibekacin. A review of their antibacterial activity and therapeutic use.
    Noone P
    Drugs; 1984 Jun; 27(6):548-78. PubMed ID: 6376062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Dibekacin blood concentration following intravenous drip infusion (author's transl)].
    Kanazawa Y
    Jpn J Antibiot; 1979 May; 32(5):624-6. PubMed ID: 459090
    [No Abstract]   [Full Text] [Related]  

  • 28. [In vitro antibacterial activity of dibekacin on staphylococci, streptococci and aerobic Gram negative bacilli].
    Deforges L; Van Thoi J; Le Soussy CJ; Duval J
    Nouv Presse Med; 1982 Nov; 11(46):3385-90. PubMed ID: 7155845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Serum concentrations and clinical efficacy of dibekacin after intravenous drip infusion to patients with respiratory tract infections].
    Soejima R; Niki Y; Matsushima T; Tano Y
    Jpn J Antibiot; 1982 Dec; 35(12):2773-7. PubMed ID: 7182533
    [No Abstract]   [Full Text] [Related]  

  • 30. In vitro comparison of kanamycin, kanendomycin, gentamicin, amikacin, sisomicin, and dibekacin against 200 strains of Pseudomonas aeruginosa.
    Paradelis AG; Douboyas J; Stathopoulos G; Grigoriadou-Edipides A; Triantaphylidis C; Papapanagiotou J
    Antimicrob Agents Chemother; 1978 Sep; 14(3):514-5. PubMed ID: 101135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gentamicin substrate-labeled fluorescent immunoassay containing monoclonal antibody.
    Place JD; Thompson SG; Clements HM; Ott RA; Jensen FC
    Antimicrob Agents Chemother; 1983 Aug; 24(2):246-51. PubMed ID: 6357072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disposition of Dibekacin in patients undergoing haemodialysis.
    Campillo JA; Lanao JM; Dominguez-Gil A; Rubio F; Martin A
    Eur J Clin Pharmacol; 1980 Oct; 18(4):347-50. PubMed ID: 7439256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Dibekacin: diffusion in bronchial mucus].
    Morel C; Vergnaud M; Langeard MM; Dupuy L; Bergogne-Berezin E
    Nouv Presse Med; 1982 Nov; 11(46):3451-5. PubMed ID: 7155857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacodynamics and pharmacokinetics of dibekacin in the neonate--comparison between the intramuscular and intravenous routes.
    Autret E; Borderon JC; Saliba E; Koki P; Ployet MJ; Gold F; Breteau M; Laugier J
    Dev Pharmacol Ther; 1984; 7 Suppl 1():121-4. PubMed ID: 6518951
    [No Abstract]   [Full Text] [Related]  

  • 35. [Therapy of surgical infections with dibekacin. Pharmacokinetic, clinical and bacteriological results].
    Sievers U; von Kobyletzki D; Primavesi CA
    Fortschr Med; 1980 Nov; 98(42):1667-70. PubMed ID: 7461562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Blood levels of dibekacin following intravenous drip infusion (author's transl)].
    Sawae Y; Hatta Y; Takii M
    Jpn J Antibiot; 1977 Sep; 30(9):667-71. PubMed ID: 916186
    [No Abstract]   [Full Text] [Related]  

  • 37. Homogeneous reactant-labeled fluorescent immunoassay for therapeutic drugs exemplified by gentamicin determination in human serum.
    Burd JF; Wong RC; Feeney JE; Carrico RJ; Boguslaski RC
    Clin Chem; 1977 Aug; 23(8):1402-8. PubMed ID: 326439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of infusion time on the pharmacokinetics of dibekacin in rabbits.
    Navarro AS; Lanao JM; Dominguez-Gil A
    J Antibiot (Tokyo); 1984 Mar; 37(3):285-92. PubMed ID: 6725142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Studies on diffusion of chemotherapeutic agents into blood, uterine, oviduct and ovary of rabbits and urinary recovery. On dibekacin (DKB) and ampicillin (ABPC) (author's transl)].
    Takabatake H; Oda T; Shiina M; Satoh Y; Ohno T
    Jpn J Antibiot; 1978 Jun; 31(6):303-6. PubMed ID: 682365
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of enzyme immunoassay, radioimmunoassay, and microbiologic assay for amikacin in plasma.
    Fukuchi H; Yoshida M; Tsukiai S; Kitaura T; Konishi T
    Am J Hosp Pharm; 1984 Apr; 41(4):690-3. PubMed ID: 6372450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.